<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68FB3A84-29CE-4F10-B27B-1482AD81759C"><gtr:id>68FB3A84-29CE-4F10-B27B-1482AD81759C</gtr:id><gtr:name>Beatson Institute for Cancer Research</gtr:name><gtr:address><gtr:line1>Garscube Estate</gtr:line1><gtr:line2>Switchback Road, Bearsden</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G61 1BD</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68FB3A84-29CE-4F10-B27B-1482AD81759C"><gtr:id>68FB3A84-29CE-4F10-B27B-1482AD81759C</gtr:id><gtr:name>Beatson Institute for Cancer Research</gtr:name><gtr:address><gtr:line1>Garscube Estate</gtr:line1><gtr:line2>Switchback Road, Bearsden</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G61 1BD</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EBABB71C-FC61-4893-95D0-894123374163"><gtr:id>EBABB71C-FC61-4893-95D0-894123374163</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Willis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A600_1023"><gtr:id>C12A0C93-7B42-432C-BCBF-031135806B60</gtr:id><gtr:title>Post-transcriptional control of gene expression following toxic injury</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A600_1023</gtr:grantReference><gtr:abstractText>Protein synthesis is the process by which the information in the genetic material in the cell, DNA, is converted via an intermediary substrate mRNA, into proteins. For proteins to be synthesised, the mRNA must interact with a large complex called the ribosome which consists of RNAs and proteins. Ribosomes are able to decode the genetic information that is held in the mRNA and carry out the synthesis of the proteins. When mammalian cells are exposed to toxic agents that can damage the cell one of the first things to happen is that protein synthesis is almost totally switched off. This is part of the cell?s defensive mechanism, since it allows the cell to repair the damage and recover from toxic injury. However, whilst overall protein synthesis is decreased under these types of conditions, certain proteins still need to be made that allow the cell to recover from the damage. We have shown previously that following treatment of cells with a range of toxic agents, for example, a commonly used chemotherapeutic drug called cisplatin, there is increased synthesis of proteins that are required to repair the damage that is caused to the DNA by this compound. We have also found that under these conditions the cells use a different mechanism to synthesise proteins. The important questions that needs to be addressed are what are the proteins that are synthesised under these conditions and how are they regulated following toxic exposure.</gtr:abstractText><gtr:technicalSummary>Following toxic cellular insult mediated by a range of agents (including UVB exposure, cisplatin and TNF related apoptosis inducing ligand, TRAIL, asbestos exposure) there is a reprogramming of protein synthesis. This reprogramming event occurs in addition to transcriptional control, although in comparison to transcription control post-transcriptional regulation has been less studied. From the systems examined thus far, the data suggest that following toxic injury subsets of mRNAs are co-ordinately regulated at a post-transcriptional level. The overall spectrum of mRNAs that are selectively translated under these conditions is specific to the type of toxic injury imposed, thus forming an essential part of the cellular response to toxic exposure. The overall aims of this programme are: A) to combine post-transcriptional and transcriptional profiling data obtained following exposure to different classes of toxic agents, to generate new models to accurately predict the effects of toxic insult; B) to carry out a detailed analysis on the RNA elements and their cognate binding proteins that permit the selective protein synthesis following toxic exposure to determine the mechanistic basis for the response; C) to examine ways in which the response to toxic injury can be modulated to enhance the efficacy of cytotoxic agents.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>9357315</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Professor Peter Fischer</gtr:description><gtr:id>7BAE7955-2C00-49CD-A078-18C92E2B6ED4</gtr:id><gtr:impact>will lead to publications</gtr:impact><gtr:outcomeId>UgZD79om7XF-1</gtr:outcomeId><gtr:partnerContribution>development of new assays</gtr:partnerContribution><gtr:piContribution>novel eIF4E inhibitors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kent</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biosciences</gtr:department><gtr:description>Translational profiling during coldshock</gtr:description><gtr:id>3A6543A5-BDC9-491F-8691-22E4AC024D9A</gtr:id><gtr:impact>This has lead to a BBSRC funded grant award and one joint publication. 3 further papers are planned</gtr:impact><gtr:outcomeId>ssjo1RXsoeF-1</gtr:outcomeId><gtr:piContribution>A joint project on cold shock has been carried out.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beatson Institute for Cancer Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>APC and translation</gtr:description><gtr:id>00979CF4-0C99-42DC-B180-FD50C63C206E</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>jWkAE65eoNu-1</gtr:outcomeId><gtr:partnerContribution>Provided mice and intellectual input</gtr:partnerContribution><gtr:piContribution>Polysome profiling, Mice from Prof O Sampson</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A97D0B88-1034-4B89-A9D5-73793CD3CC78</gtr:id><gtr:impact>Gave a talk on Toxicology to Oxford high school for girls</gtr:impact><gtr:outcomeId>58c6cbb0c7d982.55648907</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2BEEF158-0B50-4FBA-AB83-BDB786DC35CB</gtr:id><gtr:impact>300 attended lecture on Toxicology</gtr:impact><gtr:outcomeId>56d05767b3c668.28847089</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit to Uint</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C352E007-3573-4C4A-8FE0-18BE6BDD4F2C</gtr:id><gtr:impact>40 students attended the Unit, were shown how to make DNA in the laboratories and given talks on Toxicology

School found it stimulated interest in science</gtr:impact><gtr:outcomeId>qRzQdegiff4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar UCL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E65D968C-87D4-4A82-8872-83FE0E997C00</gtr:id><gtr:impact>research seminar</gtr:impact><gtr:outcomeId>56d057e8b72596.86047285</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>07C2B337-5D3E-45BC-9C4C-D6E9E6C8ACA4</gtr:id><gtr:impact>Talk about science and the theory of knowledge to 6th form students

6th form students asked for summer placements in the MRC Unit</gtr:impact><gtr:outcomeId>hN7zQUNZJu9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar Queens University Belfast</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>52FCACC5-52BD-415F-8EC3-F044AD73046C</gtr:id><gtr:impact>September 24 - Centre for Cancer Research &amp;amp; Cell Biology, Queens University, Belfast.

Interest in research area</gtr:impact><gtr:outcomeId>ci1dzfcWt5B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RNA UK cumbria conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>970DB483-0AF9-4B5F-8D94-02F2698D22E8</gtr:id><gtr:impact>stimulated interest in our research

Amandine Bastide from my laboratory was awarded a prize for best talk</gtr:impact><gtr:outcomeId>5458df64625da1.92947877</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brooke Priory school visit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FD58231C-17AA-4FD4-AB70-CA8087527EA0</gtr:id><gtr:impact>30 children spent a day making DNA in the Unit.
They had 2 lectures one of which I presented

About half the children decided that they would like to be scientists but they were only 10!</gtr:impact><gtr:outcomeId>gZhx4F5z1PD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Unit Open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F4601305-1257-4A1C-8569-DA056E6781A1</gtr:id><gtr:impact>Over 500 members of the pubic visited the Unit

Member of the public were very appreciative.
Students asked to come and carry out work experience in the Unit</gtr:impact><gtr:outcomeId>AZ2qZmBoiJx</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>conference Roscoff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>901EECEB-D0E6-4944-98A7-40E91C727806</gtr:id><gtr:impact>Talk to colleagues,

new collaborations established</gtr:impact><gtr:outcomeId>tYGqZG9uhDm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0AAE0001-26F5-425C-81E4-73DDFD8ED997</gtr:id><gtr:impact>Talk to 80 members of the public as part of the Leicester University Genie Scheme.

Well received talk</gtr:impact><gtr:outcomeId>MrCDp679bJS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar Sanquin Research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>80CE0223-0D2D-4D6B-BA46-570203509EF0</gtr:id><gtr:impact>100 researchers attended talk. Seminar and Masterclass, Sanquin Research &amp;amp; Landsteiner Lab., Amsterdam

new collaborations</gtr:impact><gtr:outcomeId>KePtZtGV8S8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CSH Conference on Translational Control, Cold Spring Harbor Laboratory, USA</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E9809600-6ACB-46E4-8CF7-11521CE7AE9B</gtr:id><gtr:impact>Lab attended CSH Translational control. We had 4 posters and one talk.

Stimulated interest in the work of the lab and promoted work in the Unit</gtr:impact><gtr:outcomeId>5458ebc5d55eb3.99014472</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>poster presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar University of Surrey</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E6C88857-0641-4526-971E-7DE06551D6EB</gtr:id><gtr:impact>May 23 - Dept. of Microbiological &amp;amp; Cellular Sciences, University of Surrey

new collaborations</gtr:impact><gtr:outcomeId>R7J2qsiDuex</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar to University of Rome Tor Vergata</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F21FD491-CEED-4BB7-AAAE-D516C9E8875B</gtr:id><gtr:impact>Research seminar, many questions

important new interactions</gtr:impact><gtr:outcomeId>5458e98daf7358.21016112</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>272E469C-7300-4769-AA24-AD9577A8127D</gtr:id><gtr:impact>Gave TV interviews about the Unit's research to ITN, BBC East midlands todays, ITV Central, Sky News and Chanel 5 news.

Huge interest in the Unit's science from the public.</gtr:impact><gtr:outcomeId>S6kHDp4oa4Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar UCL London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>23BA1F91-FF8D-4868-9F3C-85E968751FD8</gtr:id><gtr:impact>interest in research

Requests for further data</gtr:impact><gtr:outcomeId>5458dfdecbb495.12548436</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research talk (Cambridge)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F263D272-B989-4219-AE2D-A2E898FB4DBB</gtr:id><gtr:impact>Research talk,</gtr:impact><gtr:outcomeId>58c6cb51778f72.13286422</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar to Institute of Structural and Molecular Biology, UCL, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EA1E5C10-F656-486E-9676-EB7C88A7A76C</gtr:id><gtr:impact>gave a research seminar

more collaborations</gtr:impact><gtr:outcomeId>5458e053c1fa46.01322666</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar Human Genetics Unit Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DAD8010B-889E-4E6F-BB6B-67F814C9B033</gtr:id><gtr:impact>MRC Human Genetics Unit, Edinburgh

Interest in work from colleagues</gtr:impact><gtr:outcomeId>CmtziWyEppU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to the Unit of 4 16 year olds for a week work experience</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A871CC5D-E5D6-463F-BA47-9A39288402ED</gtr:id><gtr:impact>School visit by 4 16 year olds students who carried out work experience for one week in my laboratory</gtr:impact><gtr:outcomeId>58c6cc82abd3e3.45894884</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar University of Tor Vergata Rome</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E26B6564-3654-43F5-BC0B-57C7F02A3C40</gtr:id><gtr:impact>Pharmacy Summer School, University of Tor Vergata, Rome

Attended by students who showed interest in the research area</gtr:impact><gtr:outcomeId>f3SkbLQkJq7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Eurotox 2014, Edinburgh</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>395DC3D3-D597-45F2-AC66-6AE40F26278F</gtr:id><gtr:impact>Members of my lab attended EuroTox and presented 3 posters.

Stimulated interest in research carried out in the MRC Toxicology Unit</gtr:impact><gtr:outcomeId>5458ec5c1125d0.31808908</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>poster presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research Talk (Leeds)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>153663B8-5753-4BA4-ACD3-532782443A9A</gtr:id><gtr:impact>Research Talk on protein synthesis control</gtr:impact><gtr:outcomeId>58c6cc08f01f50.00230156</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar to University of W?rzburg, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6DD7CC30-8ED1-43C1-9F5E-E0B5D36A15F6</gtr:id><gtr:impact>Research talk stimulated interest

formal collaborations established</gtr:impact><gtr:outcomeId>5458eaba53a8c9.74614762</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AADD6897-3488-41B3-B9A2-B27BE789E025</gtr:id><gtr:impact>Lecture on theory of knowledge and how scientific theories are developed to year 11 IB students

Increased appreciation of scientific thought.</gtr:impact><gtr:outcomeId>ZPEjxkrghZQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Translation UK, Leicester</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8C13E5A1-8CA2-4573-9793-5AC469AF2922</gtr:id><gtr:impact>Translation UK organizer. Over 150 people attended the conference.

collaborations, stimulated discussions etc.</gtr:impact><gtr:outcomeId>5458eb5acba911.39460690</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Joint Investigator award</gtr:description><gtr:end>2021-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>8299B9B0-FBCD-4A69-BC32-0D10D07E7BE0</gtr:id><gtr:outcomeId>56d05542732632.13565222</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>340000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC project grant: Defining novel mechanisms of mRNA translational control on cold shock</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>7ADC3F2E-ED42-4AE2-85A1-605A54A0D6A5</gtr:id><gtr:outcomeId>DM4aBugAhrF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>170000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Understanding the role of eIF4B in the pathogenesis of diffuse large B cell lymphoma</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:fundingRef>14023</gtr:fundingRef><gtr:id>5674C0D9-EDA6-4259-A281-55135A3BE5CB</gtr:id><gtr:outcomeId>5458aacd069a23.06858987</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant (Co applicant with Cambridge)</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>6271603C-67D0-4D32-A104-9EACFFF74FDD</gtr:id><gtr:outcomeId>pFCGiD6cpnS</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust collaborative award</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>C5FF2279-6C19-4703-9A8B-14596C54808C</gtr:id><gtr:outcomeId>58c6c618b97ec0.49165638</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>187000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant: Post-transcriptional regulation of the DNA repair response</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>1DFCF1B1-9B0A-4BEC-87E1-CA523FB4C617</gtr:id><gtr:outcomeId>VgBQEvUpVWy0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>290000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Mouse models to understand the role of eIF4B in the pathogenesis of diffuse large B cell lymphoma</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:fundingRef>14022</gtr:fundingRef><gtr:id>43C136B3-6D9F-4666-984F-74552BA194C4</gtr:id><gtr:outcomeId>5458aa4c01edf5.07327083</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>091595</gtr:fundingRef><gtr:id>8B931CD5-C3B2-4F26-B384-B2CA3FA43CC2</gtr:id><gtr:outcomeId>iYr68Tvo8PX0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>806732</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Professorial Fellowship</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BBH)24980/1</gtr:fundingRef><gtr:id>1BCDA3C2-7A30-448C-9359-A6ECD8A63D33</gtr:id><gtr:outcomeId>gn8Udaq6ASL0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>605000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC project grant, Title translational regulation of TOP-containing mRNAs</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>55AAC464-3534-46D1-A5B6-53DFB3495C31</gtr:id><gtr:outcomeId>ZrC3HVRYnjA0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Appointments panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>65BA4855-1C40-42B2-AF53-33554958E93D</gtr:id><gtr:outcomeId>56de96796d8c33.77304900</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SIAC</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2D5ABD15-044E-4033-9191-28BFD75530AC</gtr:id><gtr:outcomeId>58c6cd29993b90.52063280</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Strategy Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B774CBB6-239A-4ACA-9BFA-9EB426400BB0</gtr:id><gtr:outcomeId>56d0585d9763b8.77464363</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of DSM committee at AZ</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9C1011D8-A447-4DA9-9BE7-EDBC74B1E1C3</gtr:id><gtr:outcomeId>58c6cd6e8ee331.77985456</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E5D9EE83-258B-4E5C-8983-7F7A4F6C98DA</gtr:id><gtr:title>An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4045ec99722c5d534bac690f76cfe482"><gtr:id>4045ec99722c5d534bac690f76cfe482</gtr:id><gtr:otherNames>Johnson LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>d1npBipjUpV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE95B2C1-773B-4F35-B1A4-8C470B61F6F8</gtr:id><gtr:title>Trans-acting translational regulatory RNA binding proteins.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. RNA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7292586bd8fe12442ccea78b60a52934"><gtr:id>7292586bd8fe12442ccea78b60a52934</gtr:id><gtr:otherNames>Harvey RF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1757-7004</gtr:issn><gtr:outcomeId>5aa13e8ba04f82.72238397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DC18C1C-3450-4997-956E-26547263B66D</gtr:id><gtr:title>Large scale integration of drug-target information reveals poly-pharmacological drug action mechanisms in tumor cell line growth inhibition assays.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bc92fafe95c6ea9d7e35409b3c85a70"><gtr:id>2bc92fafe95c6ea9d7e35409b3c85a70</gtr:id><gtr:otherNames>Knight RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>5458a8216eccf6.95314032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C883E320-59E3-4604-97FA-F55FE3C2A865</gtr:id><gtr:title>p58IPK is an inhibitor of the eIF2a kinase GCN2 and its localization and expression underpin protein synthesis and ER processing capacity.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a341e8703c906448bd76a1d0f9717362"><gtr:id>a341e8703c906448bd76a1d0f9717362</gtr:id><gtr:otherNames>Roobol A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5458a821ec1db8.87299149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC1B535B-E6A4-4493-B151-A953367067B7</gtr:id><gtr:title>Remodelling of a polypyrimidine tract-binding protein complex during apoptosis activates cellular IRESs.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10716f916a92f1e277d57baad1c31dce"><gtr:id>10716f916a92f1e277d57baad1c31dce</gtr:id><gtr:otherNames>King HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_15229_29_24141718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA445F86-1B87-4A82-97F3-7FD5A30EAF92</gtr:id><gtr:title>Control of translation in the cold: implications for therapeutic hypothermia.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bb43eadc376abbf6c6d96b46a2f16b0"><gtr:id>2bb43eadc376abbf6c6d96b46a2f16b0</gtr:id><gtr:otherNames>Knight JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>5675e525bf22a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FB1D95C-94B4-4090-AF2E-859B6F06BB16</gtr:id><gtr:title>Active regulator of SIRT1 is required for ribosome biogenesis and function.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bb43eadc376abbf6c6d96b46a2f16b0"><gtr:id>2bb43eadc376abbf6c6d96b46a2f16b0</gtr:id><gtr:otherNames>Knight JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>doi_15229_nar_gkt129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3DFF932-F4B9-42AE-B419-0C1093DFC44F</gtr:id><gtr:title>RNA binding protein/RNA element interactions and the control of translation.</gtr:title><gtr:parentPublicationTitle>Current protein &amp; peptide science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9713132b92dcd31dc9edc16fb86ed6de"><gtr:id>9713132b92dcd31dc9edc16fb86ed6de</gtr:id><gtr:otherNames>Pichon X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1389-2037</gtr:issn><gtr:outcomeId>pm_15229_29_22708490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC6355D7-C538-417A-B432-BD3DF5C4CA31</gtr:id><gtr:title>Evaluating bias-reducing protocols for RNA sequencing library preparation.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d4ab61f714736a775154711ec9bcf67"><gtr:id>8d4ab61f714736a775154711ec9bcf67</gtr:id><gtr:otherNames>Jackson TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>5458a821bfc750.09849424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9E81C49-A804-4F1D-9D42-911B4C6D634E</gtr:id><gtr:title>A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d276175cd6d2fe457c788daaa44c255"><gtr:id>6d276175cd6d2fe457c788daaa44c255</gtr:id><gtr:otherNames>Sbarrato T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c67fb9813460.35711682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D0B30F5-650F-4F82-9394-6CF7FDF3B656</gtr:id><gtr:title>The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a476ca69d63ec0e0f7ddcce688d3da4a"><gtr:id>a476ca69d63ec0e0f7ddcce688d3da4a</gtr:id><gtr:otherNames>Burrows C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>RAh95tAqqvv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66FAC3B2-3A17-4E0C-9D3C-58799550BBD4</gtr:id><gtr:title>The role of IRES trans-acting factors in regulating translation initiation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10716f916a92f1e277d57baad1c31dce"><gtr:id>10716f916a92f1e277d57baad1c31dce</gtr:id><gtr:otherNames>King HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>otJonkLu6xC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93162468-CEBD-46AB-A20E-D4022DEDE1C2</gtr:id><gtr:title>A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c6c1655c42be2ee4f690159ce345e7e"><gtr:id>3c6c1655c42be2ee4f690159ce345e7e</gtr:id><gtr:otherNames>Horvilleur E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>pm_15229_29_24135829</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2201CAC5-076E-47D8-93AF-3569EDCEC80D</gtr:id><gtr:title>Suboptimal T-cell receptor signaling compromises protein translation, ribosome biogenesis, and proliferation of mouse CD8 T cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/360670c437bae1b63d4a079a59562bb7"><gtr:id>360670c437bae1b63d4a079a59562bb7</gtr:id><gtr:otherNames>Tan TCJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5aa136c2cde781.38620173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ACBDBBA-B979-47F9-8847-428C469B6B21</gtr:id><gtr:title>The involvement of microRNAs in Type&amp;nbsp;2 diabetes.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b9440a2c5455ceea23242c0ebf37f89"><gtr:id>5b9440a2c5455ceea23242c0ebf37f89</gtr:id><gtr:otherNames>Ferland-McCollough D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>bSdVBA443zE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12799BD9-7406-4202-A292-EA043223AC50</gtr:id><gtr:title>An improved analysis methodology for translational profiling by microarray.</gtr:title><gtr:parentPublicationTitle>RNA (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d276175cd6d2fe457c788daaa44c255"><gtr:id>6d276175cd6d2fe457c788daaa44c255</gtr:id><gtr:otherNames>Sbarrato T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1355-8382</gtr:issn><gtr:outcomeId>5aa136c272ab95.92309194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA136BCC-0AF0-4288-B593-F2EEBA9C635C</gtr:id><gtr:title>Temporal Regulation of Distinct Internal Ribosome Entry Sites of the Dicistroviridae Cricket Paralysis Virus.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/791d951dab6c3dd84968c6c58101301e"><gtr:id>791d951dab6c3dd84968c6c58101301e</gtr:id><gtr:otherNames>Khong A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>58c67fb9f3df75.63943064</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A13BEB5E-BC35-4760-96DF-3D915CC8E842</gtr:id><gtr:title>Till stress do us ataRT: a novel toxin-antitoxin system targeting translation initiation.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70988a7ae9a26947599260bb621117c5"><gtr:id>70988a7ae9a26947599260bb621117c5</gtr:id><gtr:otherNames>Pizzinga M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5aa136c3199063.29468292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9A1BF39-BABE-4AA7-92B8-AF2C077FCD81</gtr:id><gtr:title>PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2a phosphorylation in established cell lines and primary human leukemia cells.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caa0b2b73adf4467fa508e8040eb0eb1"><gtr:id>caa0b2b73adf4467fa508e8040eb0eb1</gtr:id><gtr:otherNames>Yeomans A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c67fb8a70c12.85475074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5866E2C9-741D-455B-8581-E5898731DD5E</gtr:id><gtr:title>Translational Control: Selective Upregulation of ECM Components Drives Tumour Growth.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ec75263875ec6613e0b261fe21aba6d"><gtr:id>4ec75263875ec6613e0b261fe21aba6d</gtr:id><gtr:otherNames>Willis AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>58c67fb9192f24.76022290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA5015AE-070D-49A1-9137-98C5A1A3AEBB</gtr:id><gtr:title>Rapamycin regulates biochemical metabolites.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11b8def079cf2505dd3d25563d4fcb61"><gtr:id>11b8def079cf2505dd3d25563d4fcb61</gtr:id><gtr:otherNames>Tucci P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>doi_15229_1_cc_25450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDB009BB-4E3D-4FFB-95EA-BFD60F0C4D54</gtr:id><gtr:title>Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42dd50d6a147ddbe48323bf4f1e247da"><gtr:id>42dd50d6a147ddbe48323bf4f1e247da</gtr:id><gtr:otherNames>Chernova T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>58c67fb7ac84d8.65188782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59826CB9-779B-4534-972A-92B8245BCE6F</gtr:id><gtr:title>The chaperonin CCT interacts with and mediates the correct folding and activity of three subunits of translation initiation factor eIF3: b, i and h.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a341e8703c906448bd76a1d0f9717362"><gtr:id>a341e8703c906448bd76a1d0f9717362</gtr:id><gtr:otherNames>Roobol A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5458a820e83e26.21142954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A862BE7A-9206-4900-AC4C-6DBECD05005D</gtr:id><gtr:title>Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b9440a2c5455ceea23242c0ebf37f89"><gtr:id>5b9440a2c5455ceea23242c0ebf37f89</gtr:id><gtr:otherNames>Ferland-McCollough D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>pm_15229_29_22223106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7DCFED9-D5EE-42E4-9F97-FE64AC605BD0</gtr:id><gtr:title>DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8202ec23ce7877b2a6c8080563ce1fe"><gtr:id>f8202ec23ce7877b2a6c8080563ce1fe</gtr:id><gtr:otherNames>Amelio I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5458a821427893.41608922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15C02892-D7A3-466A-87CF-A5AC270CFDB5</gtr:id><gtr:title>Metabolic effects of TiO2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11b8def079cf2505dd3d25563d4fcb61"><gtr:id>11b8def079cf2505dd3d25563d4fcb61</gtr:id><gtr:otherNames>Tucci P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_15229_29_23519118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2E1B565-6F0F-43F8-AC5D-CB09EAD228FA</gtr:id><gtr:title>mTORC1-mediated translational elongation limits intestinal tumour initiation and growth.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d505f3bed1b9e4c694015f056cbc317"><gtr:id>4d505f3bed1b9e4c694015f056cbc317</gtr:id><gtr:otherNames>Faller WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545c95ba90c668.23203839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>097C7E73-45FE-4280-924C-EB1E7E782AB1</gtr:id><gtr:title>Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a45accd461e1e9d4d6142f0ea8b377b"><gtr:id>4a45accd461e1e9d4d6142f0ea8b377b</gtr:id><gtr:otherNames>Moreno JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>pm_15229_29_24107777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D0B7A48-1A95-4CA3-80E7-F2F28503ACE4</gtr:id><gtr:title>Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3457936797ccbfd7d9ba22f0029cdf0e"><gtr:id>3457936797ccbfd7d9ba22f0029cdf0e</gtr:id><gtr:otherNames>Young AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>pm_15229_29_22735379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC0EE871-3800-4BBE-8EAD-9B524261F48E</gtr:id><gtr:title>LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0cdd91384fb465e3f2f206f98879c05"><gtr:id>a0cdd91384fb465e3f2f206f98879c05</gtr:id><gtr:otherNames>Mura M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>56d05190332a64.08432138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5EF9ADB-8EEC-4B8E-84EC-0874D5E43B65</gtr:id><gtr:title>Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c24855ecb6f14958c378c4a4b3352d2f"><gtr:id>c24855ecb6f14958c378c4a4b3352d2f</gtr:id><gtr:otherNames>Tufi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>5458a8211cf234.61593701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C01E24B2-A603-43FE-91A5-9D0AAF3C4065</gtr:id><gtr:title>Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-a infliximab.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fa8c3198b4789ca282cbe620271dfde"><gtr:id>1fa8c3198b4789ca282cbe620271dfde</gtr:id><gtr:otherNames>Chimenti MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>doi_15229_1_cc_26067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A690B91E-C7B0-440C-8F3C-E1045472EE09</gtr:id><gtr:title>Sustained translational repression by eIF2a-P mediates prion neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a45accd461e1e9d4d6142f0ea8b377b"><gtr:id>4a45accd461e1e9d4d6142f0ea8b377b</gtr:id><gtr:otherNames>Moreno JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15229_29_22622579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4335EB80-D65B-4C3B-9A13-6E945B8CEC3C</gtr:id><gtr:title>eIF4A inhibition allows translational regulation of mRNAs encoding proteins involved in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89251a5597f0e326e1aa124a97b7d03"><gtr:id>f89251a5597f0e326e1aa124a97b7d03</gtr:id><gtr:otherNames>Bottley A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>EGjpu6A71sn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4992918D-EC41-42AA-BD58-F2E68A44C195</gtr:id><gtr:title>Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa1b253a54bc8f68f3a79c411950a42c"><gtr:id>aa1b253a54bc8f68f3a79c411950a42c</gtr:id><gtr:otherNames>Meijer HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>doi_15229_ce_1231197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AA297EF-6294-46D3-89B4-A6D25E96C250</gtr:id><gtr:title>Cap-Independent Translation in Hematological Malignancies.</gtr:title><gtr:parentPublicationTitle>Frontiers in oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c6c1655c42be2ee4f690159ce345e7e"><gtr:id>3c6c1655c42be2ee4f690159ce345e7e</gtr:id><gtr:otherNames>Horvilleur E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2234-943X</gtr:issn><gtr:outcomeId>56d0522ae2b415.87461315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B6CB76F-FE56-4592-9FD6-01A2F707ECBE</gtr:id><gtr:title>Post-transcriptional control of gene expression following stress: the role of RNA-binding proteins.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0605225f90f3ae2192dd3ad02050b8ca"><gtr:id>0605225f90f3ae2192dd3ad02050b8ca</gtr:id><gtr:otherNames>Harvey R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>5aa136c2ab9ad2.10867690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49AAA51B-96F1-4A7D-BDBF-C31E12A16EAB</gtr:id><gtr:title>The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67617699038acba2aa845bc86eccce99"><gtr:id>67617699038acba2aa845bc86eccce99</gtr:id><gtr:otherNames>Hall BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5458a8219768c6.95598603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2D34F6D-10AE-488D-95BC-A3C80324F315</gtr:id><gtr:title>A common polymorphism in the 5' UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d038e0d1090b2fc29e384ade1a828ca"><gtr:id>0d038e0d1090b2fc29e384ade1a828ca</gtr:id><gtr:otherNames>Somers J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>56d0522a92b301.41194223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D35B1B13-EDC1-482B-94EF-2F70227A9F0C</gtr:id><gtr:title>Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf).</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42dd50d6a147ddbe48323bf4f1e247da"><gtr:id>42dd50d6a147ddbe48323bf4f1e247da</gtr:id><gtr:otherNames>Chernova T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>5aa136c35f8e34.32936152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F035C51F-FA4D-41C8-AFD9-85D2CA0E7A17</gtr:id><gtr:title>Translation deregulation in B-cell lymphomas.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c6c1655c42be2ee4f690159ce345e7e"><gtr:id>3c6c1655c42be2ee4f690159ce345e7e</gtr:id><gtr:otherNames>Horvilleur E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>i2ufrmChUmX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AAB62EA-9118-48BC-ACBE-524387FF75F7</gtr:id><gtr:title>eIF4A1 is a promising new therapeutic target in ER-negative breast cancer.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b75aaa1914579bea08c1df2aee9b1a9"><gtr:id>4b75aaa1914579bea08c1df2aee9b1a9</gtr:id><gtr:otherNames>Stoneley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>56d051905c5810.14245984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF8940B8-EA7F-4B04-A19C-4F858747BB41</gtr:id><gtr:title>Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95e1b076014d57e2d17bf31c72abb572"><gtr:id>95e1b076014d57e2d17bf31c72abb572</gtr:id><gtr:otherNames>Delaunay S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>58c67fb73998b4.33433518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C63722B-2FC7-4B74-997C-09B6B2AD92A3</gtr:id><gtr:title>p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23a0c377cb6705549698d75082987254"><gtr:id>23a0c377cb6705549698d75082987254</gtr:id><gtr:otherNames>Cannell IG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>dN5UVoLmdRL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB5830AA-A398-4595-BD54-CFB5AEAA9DAC</gtr:id><gtr:title>Eukaryotic elongation factor 2 kinase regulates the cold stress response by slowing translation elongation.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bb43eadc376abbf6c6d96b46a2f16b0"><gtr:id>2bb43eadc376abbf6c6d96b46a2f16b0</gtr:id><gtr:otherNames>Knight JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5458a78ba18d73.97033767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BACEEE85-D2B0-433E-8D4B-6B175732EA62</gtr:id><gtr:title>Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3106b3468d94f02d9362d5e6205652ec"><gtr:id>3106b3468d94f02d9362d5e6205652ec</gtr:id><gtr:otherNames>Hertz MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>doi_15229_B_00879_12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F5ABC7F-4B39-41BB-AECF-69C16A1DB22D</gtr:id><gtr:title>Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99e38b4b16a3ec5a055bd694e8ca1e76"><gtr:id>99e38b4b16a3ec5a055bd694e8ca1e76</gtr:id><gtr:otherNames>Cobbold LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>bkK39jwe665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>730D867E-9F31-49BD-A028-43FB35B77952</gtr:id><gtr:title>Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caa0b2b73adf4467fa508e8040eb0eb1"><gtr:id>caa0b2b73adf4467fa508e8040eb0eb1</gtr:id><gtr:otherNames>Yeomans A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56d0522abd4ba4.23319927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94544F16-1A77-4977-9AE2-CF076E09588B</gtr:id><gtr:title>A perspective on mammalian upstream open reading frame function.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d038e0d1090b2fc29e384ade1a828ca"><gtr:id>0d038e0d1090b2fc29e384ade1a828ca</gtr:id><gtr:otherNames>Somers J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>doi_15229_013_04_020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E56CB5-A0AC-4418-8F45-E04BEFDECDDF</gtr:id><gtr:title>Translational regulation of gene expression during conditions of cell stress.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae5a933e7aa78460d5fe176c1565da7a"><gtr:id>ae5a933e7aa78460d5fe176c1565da7a</gtr:id><gtr:otherNames>Spriggs KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>p4QAHmVBnxH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4CEB10C-85DD-434D-95D8-33969050EF89</gtr:id><gtr:title>The biological and therapeutic relevance of mRNA translation in cancer.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Clinical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea66b2b4145e915d29b93c2689c2ddbd"><gtr:id>ea66b2b4145e915d29b93c2689c2ddbd</gtr:id><gtr:otherNames>Blagden SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1759-4774</gtr:issn><gtr:outcomeId>QVTsxMvQeLJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>663476A2-5133-4AF1-BE15-1F1881ABBA5D</gtr:id><gtr:title>Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a31dad6535de58bb47eca00e575f9642"><gtr:id>a31dad6535de58bb47eca00e575f9642</gtr:id><gtr:otherNames>Falletta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>5aa136c33de881.89134982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>046F334A-7F07-4018-A097-D8B00366F07C</gtr:id><gtr:title>RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0042775cd42f8bf4ca5f19c31c440848"><gtr:id>0042775cd42f8bf4ca5f19c31c440848</gtr:id><gtr:otherNames>Peretti D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d0515c4da260.06289247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CF14CBE-79FC-4464-8C4F-F272CF2BB5C7</gtr:id><gtr:title>TRANS PROF DB: A new resource for sharing translational profiles.</gtr:title><gtr:parentPublicationTitle>Translation (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9be0d673689da834b61b6290b2d089f"><gtr:id>d9be0d673689da834b61b6290b2d089f</gtr:id><gtr:otherNames>Spriggs RV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2169-0731</gtr:issn><gtr:outcomeId>56d0522a2c2d11.06889959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3EF5EB7-0B68-46FB-BDB3-B9F5C4514C55</gtr:id><gtr:title>ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a341e8703c906448bd76a1d0f9717362"><gtr:id>a341e8703c906448bd76a1d0f9717362</gtr:id><gtr:otherNames>Roobol A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>bn3CMWxaGBK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0CC717F-06BB-4534-8272-4597BF0241A1</gtr:id><gtr:title>RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/638c314c0ef6e190e8a7f3529ecb699f"><gtr:id>638c314c0ef6e190e8a7f3529ecb699f</gtr:id><gtr:otherNames>Bastide A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>5aa1349dcad1a4.91162721</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A600_1023</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>